April 22, 2025CorporateTerumo unveils “Terumo Group Statement on Nature,” a guideline for its actions on conservation and restoration of natural environments
April 16, 2025CorporateTerumo Blood and Cell Technologies Names Patrick Daly as Chief Business OfficerDaly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth
April 16, 2025CorporateTerumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US– Innovative AI software supports hospital adoption of advanced tools to improve cath lab workflow and patient comfort –
Refining Searches 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Corporate Financial August 07, 2015 Financial Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 84.38 KB) August 04, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 60.58 KB) June 24, 2015 Financial Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures" May 28, 2015 Corporate Terumo to Support Relief Efforts Following Nepal Earthquake May 19, 2015 Corporate Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies (ART) May 08, 2015 Corporate Notice Concerning Members of the Board of Directors after the Transition to a Company with an Audit/Supervisory Committee (PDF 56.07 KB) May 08, 2015 Financial Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB) April 23, 2015 Corporate Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB) April 23, 2015 Corporate Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB) April 17, 2015 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA) April 10, 2015 Corporate Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine April 06, 2015 Corporate Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology March 27, 2015 Corporate FAMHP advises patients to not suspend nor stop any treatments March 23, 2015 Corporate Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients February 12, 2015 Corporate Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area February 03, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB) Pagination Previous page ‹ Page1 … Page8 Page9 Current page10 Next page ›
August 07, 2015 Financial Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 84.38 KB)
August 04, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 60.58 KB)
June 24, 2015 Financial Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures"
May 19, 2015 Corporate Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies (ART)
May 08, 2015 Corporate Notice Concerning Members of the Board of Directors after the Transition to a Company with an Audit/Supervisory Committee (PDF 56.07 KB)
May 08, 2015 Financial Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB)
April 23, 2015 Corporate Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB)
April 23, 2015 Corporate Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB)
April 17, 2015 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)
April 10, 2015 Corporate Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine
April 06, 2015 Corporate Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology
March 23, 2015 Corporate Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients
February 12, 2015 Corporate Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area
February 03, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB)
Top
Top